According to a new report from Tufts Center for the Study of Drug Development (Tufts CSDD), although many pharmaceutical companies are increasing the pace of new products by improving the efficiency of clinical trial operations, their medium- and long-term success will increasingly depend on their ability to support more efficient research and development (R&D) models.
![worldwide-total-pharma-rd-spending-2004-2018.jpg Worldwide total pharma R&D spending 2004-2018](https://www.highlighthealth.com/wp-content/uploads/2014/01/worldwide-total-pharma-rd-spending-2004-2018.jpg)